UBS O'Connor’s Clarivate CLVT Stock Holding History

UBS O'Connor’s Portfolio CLVT Stock Details CLVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50,000	Closed	-$1.09M	–	954
2021 Q3	$1.09M	Sell	50,000 -75,000	-60%	-$1.82M	0.01%	603
2021 Q2	$3.44M	Buy	+125,000	New	+$3.44M	0.03%	361

Other funds holding CLVT

LGP

Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Atairos Group Bryn Mawr, Pennsylvania $1.76B AUM 16.47% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

UBS O'Connor's CLVT Position: Q4 2021 in Review

UBS O'Connor sold out of Clarivate (CLVT) in Q4 2021, closing a stake of 50,000 shares — an estimated $1.09M sold.

UBS O'Connor first reported a position in CLVT in Q2 2021 and held it in 2 quarters. The position peaked at $3.44M in Q2 2021. 290 funds tracked by Wall St. Rank hold CLVT as of Q4 2021.

UBS O'Connor reported no remaining Clarivate position as of Q4 2021 after selling out during the quarter.
UBS O'Connor sold 50,000 Clarivate shares in Q4 2021, an estimated $1.09M.
UBS O'Connor first reported a position in Clarivate in Q2 2021 and held it in 2 quarters.
UBS O'Connor's Clarivate position peaked at $3.44M in Q2 2021.
290 funds tracked by Wall St. Rank held Clarivate as of Q4 2021.

Based on UBS O'Connor's 13F filing for Q4 2021, filed 14 Feb 2022.